Cargando…

Extensively drug-resistant (XDR) Neisseria gonorrhoeae causing possible gonorrhoea treatment failure with ceftriaxone plus azithromycin in Austria, April 2022

We describe a gonorrhoea case with ceftriaxone plus high-level azithromycin resistance. In April 2022, an Austrian heterosexual male was diagnosed with gonorrhoea after sexual intercourse with a female sex worker in Cambodia. Recommended treatment with ceftriaxone (1 g) plus azithromycin (1.5 g) pos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pleininger, Sonja, Indra, Alexander, Golparian, Daniel, Heger, Florian, Schindler, Stefanie, Jacobsson, Susanne, Heidler, Stefan, Unemo, Magnus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2022
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205165/ https://www.ncbi.nlm.nih.gov/pubmed/35713023 http://dx.doi.org/10.2807/1560-7917.ES.2022.27.24.2200455

Ejemplares similares

Complete Reference Genome Sequence of the Extensively Drug-Resistant Strain Neisseria gonorrhoeae AT159, with Ceftriaxone Resistance and High-Level Azithromycin Resistance, Using Nanopore Q20+ Chemistry and Illumina Sequencing
por: Golparian, Daniel, et al.
Publicado: (2022)

Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018
por: Eyre, David W, et al.
Publicado: (2018)

Multidrug-resistant Neisseria gonorrhoeae infection with ceftriaxone resistance and intermediate resistance to azithromycin, Denmark, 2017
por: Terkelsen, David, et al.
Publicado: (2017)

Ceftriaxone-resistant, multidrug-resistant Neisseria gonorrhoeae with a novel mosaic penA-237.001 gene, France, June 2022
por: Berçot, Béatrice, et al.
Publicado: (2022)

Multidrug-resistant Neisseria gonorrhoeae isolate, belonging to the internationally spreading Japanese FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, Ireland, August 2018
por: Golparian, Daniel, et al.
Publicado: (2018)

Two cases of extensively drug-resistant (XDR) Neisseria gonorrhoeae infection combining ceftriaxone-resistance and high-level azithromycin resistance, France, November 2022 and May 2023
por: Maubaret, Clara, et al.
Publicado: (2023)

Genetic relatedness of ceftriaxone-resistant and high-level azithromycin resistant Neisseria gonorrhoeae cases, United Kingdom and Australia, February to April 2018
por: Jennison, Amy V, et al.
Publicado: (2019)

Multidrug-resistant Neisseria gonorrhoeae isolate SE690: mosaic penA-60.001 gene causing ceftriaxone resistance internationally has spread to the more antimicrobial-susceptible genomic lineage, Sweden, September 2022
por: Golparian, Daniel, et al.
Publicado: (2023)

Detection of 10 cases of ceftriaxone-resistant Neisseria gonorrhoeae in the United Kingdom, December 2021 to June 2022
por: Day, Michaela, et al.
Publicado: (2022)

Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016
por: Day, Michaela J., et al.
Publicado: (2018)

Detection in the United Kingdom of the Neisseria gonorrhoeae FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, October to December 2018
por: Eyre, David W, et al.
Publicado: (2019)

Genomic Epidemiology of Azithromycin-Nonsusceptible Neisseria gonorrhoeae, Argentina, 2005–2019
por: Gianecini, Ricardo Ariel, et al.
Publicado: (2021)

Markedly decreasing azithromycin susceptibility of Neisseria gonorrhoeae, Germany, 2014 to 2021
por: Selb, Regina, et al.
Publicado: (2021)

Azithromycin Resistance and Decreased Ceftriaxone Susceptibility in Neisseria gonorrhoeae, Hawaii, USA
por: Papp, John R., et al.
Publicado: (2017)

Significant increase in azithromycin “resistance” and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019
por: Day, Michaela J., et al.
Publicado: (2022)

Association of Phylogenomic Relatedness among Neisseria gonorrhoeae Strains with Antimicrobial Resistance, Austria, 2016–2020
por: Schaeffer, Justine, et al.
Publicado: (2022)

In vitro activity of the novel oral antimicrobial SMT-571, with a new mechanism of action, against MDR and XDR Neisseria gonorrhoeae: future treatment option for gonorrhoea?
por: Jacobsson, Susanne, et al.
Publicado: (2019)

Ceftriaxone-Resistant Neisseria gonorrhoeae, Japan
por: Ohnishi, Makoto, et al.
Publicado: (2011)

Antimicrobial resistance in Neisseria gonorrhoeae isolates and gonorrhoea treatment in the Republic of Belarus, Eastern Europe, 2009–2019
por: Aniskevich, Aliaksandra, et al.
Publicado: (2021)

Rifampicin Resistance Associated with rpoB Mutations in Neisseria gonorrhoeae Clinical Strains Isolated in Austria, 2016 to 2020
por: Schaeffer, Justine, et al.
Publicado: (2022)

Ceftriaxone-Resistant Neisseria gonorrhoeae, Canada, 2017
por: Katz, Alan R.
Publicado: (2018)

Ceftriaxone-Resistant Neisseria gonorrhoeae, Canada, 2017
por: Lefebvre, Brigitte, et al.
Publicado: (2018)

Neisseria gonorrhoeae Resistant to Ceftriaxone and Cefixime, Argentina
por: Gianecini, Ricardo, et al.
Publicado: (2016)

Now Is the Time to Implement Whole Genome Sequencing in the Global Antimicrobial Resistance Surveillance for Neisseria gonorrhoeae?
por: Golparian, Daniel, et al.
Publicado: (2019)

High in vitro activity of DIS-73285, a novel antimicrobial with a new mechanism of action, against MDR and XDR Neisseria gonorrhoeae
por: Jacobsson, Susanne, et al.
Publicado: (2020)

Neisseria gonorrhoeae Aggregation Reduces Its Ceftriaxone Susceptibility
por: Wang, Liang-Chun, et al.
Publicado: (2018)

Pharmacodynamics of Ceftriaxone, Ertapenem, Fosfomycin and Gentamicin in Neisseria gonorrhoeae
por: Gubenšek, Urša, et al.
Publicado: (2022)

Sustained Transmission of Neisseria gonorrhoeae Strains with High-Level Azithromycin Resistance (MIC ≥ 256 μg/mL) in Argentina, 2018 to 2022
por: Gianecini, Ricardo Ariel, et al.
Publicado: (2023)

Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015
por: Wind, Carolien M, et al.
Publicado: (2017)

Systematic review and survey of Neisseria gonorrhoeae ceftriaxone and azithromycin susceptibility data in the Asia Pacific, 2011 to 2016
por: George, C. R. Robert, et al.
Publicado: (2019)

In Vitro Efficacy of Gentamicin Alone and in Combination with Ceftriaxone, Ertapenem, and Azithromycin against Multidrug-Resistant Neisseria gonorrhoeae
por: Li, Xuechun, et al.
Publicado: (2021)

In Vitro Study of the Interaction of Gentamicin with Ceftriaxone and Azithromycin against Neisseria gonorrhoeae Using Agar Dilution Method
por: Xu, Wenqi, et al.
Publicado: (2022)

Complete Reference Genome Sequence of the Clinical Neisseria gonorrhoeae Strain H035, with Resistance to the Novel Antimicrobial Zoliflodacin, Identified in Japan in 2000
por: Golparian, Daniel, et al.
Publicado: (2023)

Current and future antimicrobial treatment of gonorrhoea – the rapidly evolving Neisseria gonorrhoeae continues to challenge
por: Unemo, Magnus
Publicado: (2015)

Genetic variation regulates the activation and specificity of Restriction-Modification systems in Neisseria gonorrhoeae
por: Sánchez-Busó, Leonor, et al.
Publicado: (2019)

Identification of multidrug-resistant Neisseria gonorrhoeae isolates with combined resistance to both ceftriaxone and azithromycin, China, 2017–2018
por: Yuan, Qianqin, et al.
Publicado: (2019)

Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from Vietnam, 2011
por: Olsen, Birgitta, et al.
Publicado: (2013)

Antimicrobial resistance and molecular epidemiological typing of Neisseria gonorrhoeae isolates from Kyrgyzstan in Central Asia, 2012 and 2017
por: Karymbaeva, Saliya, et al.
Publicado: (2021)

Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015
por: Cole, Michelle J., et al.
Publicado: (2017)

Azithromycin-resistant Neisseria gonorrhoeae isolates in Guangzhou, China (2009–2013): coevolution with decreased susceptibilities to ceftriaxone and genetic characteristics
por: Liang, Jing-Yao, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_221mu91q9cn9g8ji26mc81fc9j